Literature DB >> 23706501

The impact of dry eye disease on visual performance while driving.

Nathalie Deschamps1, Xavier Ricaud, Ghislaine Rabut, Antoine Labbé, Christophe Baudouin, Alexandre Denoyer.   

Abstract

PURPOSE: A specific simulator was used to assess the driving visual performance in patients with dry eye disease (DED) and to determine clinical predictors of visual impairments while driving.
DESIGN: Prospective case-control study.
METHODS: The study was conducted in the Center for Clinical Investigation of Quinze-Vingts National Ophthalmology Hospital, Paris, France. Twenty dry eye patients and 20 age- and sex-matched control subjects were included. Vision-related driving ability was assessed using a specific driving simulator displaying randomly located targets with a progressive increase in contrast to be identified. Other examinations included clinical examinations, serial measurements of corneal higher-order aberrations (HOAs), and vision-related quality-of-life questionnaire (Ocular Surface Disease Index [OSDI]). Data collected during driving test (ie, the number of targets seen, their position, and the response time) were compared between groups and analyzed according to clinical data, aberration dynamics, and quality-of-life index.
RESULTS: The percentage of targets missed as well as average response time were significantly increased in DED patients as compared with controls (P < .01). More specifically, the visual function of DED patients was more impaired in specific situations, such as crossroad or roundabout approaches. In DED patients, the response time was found to positively correlate with the progression index for HOAs (P < .01) and with the OSDI "symptoms" subscale (P < .05).
CONCLUSIONS: Degradation of ocular optical qualities related to DED is associated with visual impairments during driving. This study objectively has demonstrated the impact of tear film-related aberration changes on activities of daily living in DED.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23706501     DOI: 10.1016/j.ajo.2013.02.019

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  19 in total

1.  Characteristics of symptoms experienced by persons with dry eye disease while driving in China.

Authors:  Y Wang; H Lv; Y Liu; X Jiang; M Zhang; X Li; W Wang
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

Review 2.  The pathophysiology, diagnosis, and treatment of dry eye disease.

Authors:  Elisabeth M Messmer
Journal:  Dtsch Arztebl Int       Date:  2015-01-30       Impact factor: 5.594

3.  Dry eye disease and psychiatric disorders: A systematic review and meta-analysis.

Authors:  Amy Basilious; Cathy Y Xu; Monali S Malvankar-Mehta
Journal:  Eur J Ophthalmol       Date:  2021-12-22       Impact factor: 1.922

4.  Impact of epiphora on vision-related quality of life.

Authors:  Jae-Ho Shin; Yoon-Duck Kim; Kyung In Woo
Journal:  BMC Ophthalmol       Date:  2015-01-21       Impact factor: 2.209

5.  The Correlation Analysis between Corneal Biomechanical Properties and the Surgically Induced Corneal High-Order Aberrations after Small Incision Lenticule Extraction and Femtosecond Laser In Situ Keratomileusis.

Authors:  Wenjing Wu; Yan Wang
Journal:  J Ophthalmol       Date:  2015-09-21       Impact factor: 1.909

6.  A new dry eye mouse model produced by exorbital and intraorbital lacrimal gland excision.

Authors:  Katsuhiko Shinomiya; Mayumi Ueta; Shigeru Kinoshita
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

7.  Proinflammatory Markers, Chemokines, and Enkephalin in Patients Suffering from Dry Eye Disease.

Authors:  Pierre Nicolle; Hong Liang; Elodie Reboussin; Ghislaine Rabut; Elise Warcoin; Françoise Brignole-Baudouin; Stéphane Melik-Parsadaniantz; Christophe Baudouin; Antoine Labbe; Annabelle Reaux-Le Goazigo
Journal:  Int J Mol Sci       Date:  2018-04-17       Impact factor: 5.923

8.  The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye.

Authors:  Karl G Stonecipher; Gail L Torkildsen; George W Ousler; Scot Morris; Linda Villanueva; David A Hollander
Journal:  Clin Ophthalmol       Date:  2016-05-13

Review 9.  Dry eye syndrome: developments and lifitegrast in perspective.

Authors:  Ivonne V Lollett; Anat Galor
Journal:  Clin Ophthalmol       Date:  2018-01-15

10.  Impact of Dry Eye Disease on Vision Quality: An Optical Quality Analysis System Study.

Authors:  Antoine Herbaut; Hong Liang; Ghislaine Rabut; Liem Trinh; Karima Kessal; Christophe Baudouin; Antoine Labbé
Journal:  Transl Vis Sci Technol       Date:  2018-07-12       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.